Sir Richard Timothy Hunt, PhD
Emeritus Group Leader, Clare Hall Laboratories, Cancer Research UK, London, England
A recipient of the 2001 Nobel Prize in Physiology or Medicine, Dr. Hunt initially conducted studies of hemoglobin synthesis and translational control. These studies eventually led to the discovery of cyclins and cyclin-dependent kinases (CDKs). Further analysis of these protein families demonstrated that cyclins are responsible for the activation of cyclin-dependent kinases, an event required for completion of the cell cycle.
Dr. Hunt’s studies illuminated our understanding of cellular division and the cell cycle and have been essential to the evolution of promising cancer therapeutics. Several clinical trials are currently ongoing for the use of CDK inhibitors against a wide range of cancer types.
2006 Elected Member, National Academy of Sciences, Washington, DC2006 Knighted, Queen’s Birthday Honor List2006 Queen’s Medal, Royal Society, London2002 Officer, Legion of Honor (France)2001 Nobel Prize in Physiology or Medicine1999 Elected Foreign Associate, National Academy of Sciences, Washington, DC1998 Founder, UK Academy of Medical Sciences1993 Abraham White Scientific Achievement Award of the George Washington University1991 Elected Fellow, Royal Society, London1991 Scientific Director, Imperial Cancer Research Fund1990 Head, Cell Cycle Control Laboratory, Imperial Cancer Research Fund1968 PhD, University of Cambridge